List of Tables
Table 1. Urological Medications Market Trends
Table 2. Urological Medications Market Drivers & Opportunity
Table 3. Urological Medications Market Challenges
Table 4. Urological Medications Market Restraints
Table 5. Global Urological Medications Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Urological Medications Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Urological Medications Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Urological Medications Product Type
Table 9. Key Companies Time to Begin Mass Production of Urological Medications
Table 10. Global Urological Medications Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Urological Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Urological Medications Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Urological Medications Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Urological Medications Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Urological Medications Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Urological Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Urological Medications Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Urological Medications Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Urological Medications Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Urological Medications Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Urological Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Urological Medications Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Urological Medications Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Urological Medications Sales Value by Region (2019-2024) & (%)
Table 27. Global Urological Medications Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Urological Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Urological Medications Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Urological Medications Sales Value, (2025-2030) & (US$ Million)
Table 31. Viatris Basic Information List
Table 32. Viatris Description and Business Overview
Table 33. Viatris Urological Medications Products, Services and Solutions
Table 34. Revenue (US$ Million) in Urological Medications Business of Viatris (2019-2024)
Table 35. Viatris Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Urological Medications Products, Services and Solutions
Table 39. Revenue (US$ Million) in Urological Medications Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Merck Basic Information List
Table 42. Merck Description and Business Overview
Table 43. Merck Urological Medications Products, Services and Solutions
Table 44. Revenue (US$ Million) in Urological Medications Business of Merck (2019-2024)
Table 45. Merck Recent Developments
Table 46. Astellas Pharma Basic Information List
Table 47. Astellas Pharma Description and Business Overview
Table 48. Astellas Pharma Urological Medications Products, Services and Solutions
Table 49. Revenue (US$ Million) in Urological Medications Business of Astellas Pharma (2019-2024)
Table 50. Astellas Pharma Recent Developments
Table 51. Abbott Basic Information List
Table 52. Abbott Description and Business Overview
Table 53. Abbott Urological Medications Products, Services and Solutions
Table 54. Revenue (US$ Million) in Urological Medications Business of Abbott (2019-2024)
Table 55. Abbott Recent Developments
Table 56. ADVANZ PHARMA Basic Information List
Table 57. ADVANZ PHARMA Description and Business Overview
Table 58. ADVANZ PHARMA Urological Medications Products, Services and Solutions
Table 59. Revenue (US$ Million) in Urological Medications Business of ADVANZ PHARMA (2019-2024)
Table 60. ADVANZ PHARMA Recent Developments
Table 61. GlaxoSmithKline Basic Information List
Table 62. GlaxoSmithKline Description and Business Overview
Table 63. GlaxoSmithKline Urological Medications Products, Services and Solutions
Table 64. Revenue (US$ Million) in Urological Medications Business of GlaxoSmithKline (2019-2024)
Table 65. GlaxoSmithKline Recent Developments
Table 66. Bayer HealthCare Pharmaceuticals Basic Information List
Table 67. Bayer HealthCare Pharmaceuticals Description and Business Overview
Table 68. Bayer HealthCare Pharmaceuticals Urological Medications Products, Services and Solutions
Table 69. Revenue (US$ Million) in Urological Medications Business of Bayer HealthCare Pharmaceuticals (2019-2024)
Table 70. Bayer HealthCare Pharmaceuticals Recent Developments
Table 71. Novartis Basic Information List
Table 72. Novartis Description and Business Overview
Table 73. Novartis Urological Medications Products, Services and Solutions
Table 74. Revenue (US$ Million) in Urological Medications Business of Novartis (2019-2024)
Table 75. Novartis Recent Developments
Table 76. Piramal Pharma Solutions Basic Information List
Table 77. Piramal Pharma Solutions Description and Business Overview
Table 78. Piramal Pharma Solutions Urological Medications Products, Services and Solutions
Table 79. Revenue (US$ Million) in Urological Medications Business of Piramal Pharma Solutions (2019-2024)
Table 80. Piramal Pharma Solutions Recent Developments
Table 81. Endo International Basic Information List
Table 82. Endo International Description and Business Overview
Table 83. Endo International Urological Medications Products, Services and Solutions
Table 84. Revenue (US$ Million) in Urological Medications Business of Endo International (2019-2024)
Table 85. Endo International Recent Developments
Table 86. Sanofi-aventis U.S. LLC Basic Information List
Table 87. Sanofi-aventis U.S. LLC Description and Business Overview
Table 88. Sanofi-aventis U.S. LLC Urological Medications Products, Services and Solutions
Table 89. Revenue (US$ Million) in Urological Medications Business of Sanofi-aventis U.S. LLC (2019-2024)
Table 90. Sanofi-aventis U.S. LLC Recent Developments
Table 91. AbbVie Basic Information List
Table 92. AbbVie Description and Business Overview
Table 93. AbbVie Urological Medications Products, Services and Solutions
Table 94. Revenue (US$ Million) in Urological Medications Business of AbbVie (2019-2024)
Table 95. AbbVie Recent Developments
Table 96. Mallinckrodt Basic Information List
Table 97. Mallinckrodt Description and Business Overview
Table 98. Mallinckrodt Urological Medications Products, Services and Solutions
Table 99. Revenue (US$ Million) in Urological Medications Business of Mallinckrodt (2019-2024)
Table 100. Mallinckrodt Recent Developments
Table 101. Lilly Basic Information List
Table 102. Lilly Description and Business Overview
Table 103. Lilly Urological Medications Products, Services and Solutions
Table 104. Revenue (US$ Million) in Urological Medications Business of Lilly (2019-2024)
Table 105. Lilly Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Urological Medications Downstream Customers
Table 109. Urological Medications Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Urological Medications Product Picture
Figure 2. Global Urological Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 4. Urological Medications Report Years Considered
Figure 5. Global Urological Medications Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Urological Medications Revenue in 2023
Figure 7. Urological Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Alpha Blockers Picture
Figure 9. 5-Alpha Inhibitors Picture
Figure 10. Anticholinergics Picture
Figure 11. Others Picture
Figure 12. Global Urological Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Urological Medications Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of SUI
Figure 15. Product Picture of BPH
Figure 16. Product Picture of OAB
Figure 17. Product Picture of ED
Figure 18. Product Picture of Prostate Cancer
Figure 19. Product Picture of Others
Figure 20. Global Urological Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Urological Medications Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Urological Medications Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Urological Medications Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Urological Medications Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Urological Medications Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Urological Medications Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Urological Medications Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Urological Medications Sales Value (%), (2019-2030)
Figure 33. United States Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 39. China Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 41. China Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 51. India Urological Medications Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Urological Medications Sales Value by Type (%), 2023 VS 2030
Figure 53. India Urological Medications Sales Value by Application (%), 2023 VS 2030
Figure 54. Urological Medications Industrial Chain
Figure 55. Urological Medications Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
